6 results on '"Arampatzi, K"'
Search Results
2. Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach
- Author
-
Theodorakis, M.J. Katsiki, N. Arampatzi, K. Chrousos, G.P.
- Abstract
Objective: The conventional approach to analyzing data from oral glucose tolerance testing (OGTT) requires model identification in each individual separately (standard two stage, STS), ignoring knowledge about the population as a whole. In practice, however, the OGTT is sparsely sampled and individual estimates are often not resolvable from available data. This weakness is often encountered in large scale trials or epidemiological studies, leading to either multiple imputations or simply much less data available for analysis. Methods: We have applied a population approach, nonlinear mixed effects modeling, to plasma glucose, insulin and C-peptide data obtained from a 120 minute OGTT undertaken by 106 subjects with varying glucose tolerance. This method provides estimates of population means, variances and covariances of model parameters and empirical Bayes estimates of individual parameter values, as well as measures of intra-individual (within-subject) and inter-individual (between-subject) variability. The recently developed oral glucose minimal model was used to evaluate insulin sensitivity, and a combined model approach was used to assess β-cell secretion. Results: Applying these models allowed for the reconstruction of insulin secretion and glucose absorption profiles and gave population indexes of insulin sensitivity (SI = 6.51 ± 1.20 × 10−4 min−1·μU−1·ml), fractional hepatic extraction of insulin (F = 0.522 ± 0.291) and fractional insulin clearance (kI = 0.258 ± 0.151 min−1). Whereas the traditional approach to parameter estimation failed to recover estimates in more than one third of the population, the population approach provided individual estimates in all subjects. Examination of the empirical Bayes estimates showed that individual parameter estimates were able to differentiate well between individuals at glucose tolerant states ranging from euglycemia to overt type 2 diabetes. Conclusions: Our findings suggest that population analysis is a powerful tool for obtaining accurate assessments of indexes of insulin sensitivity and β-cell function from the OGTT, especially in epidemiological studies with large numbers of sparsely sampled subjects. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
- Published
- 2017
3. Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia
- Author
-
Matarese G, La Rocca C, Moon HS, Huh JY, Brinkoetter MT, Chou S, Perna F, Greco D, Kilim HP, Gao C, Arampatzi K, Wang Z, and Mantzoros CS.
- Subjects
metreleptin ,CD4+ ,T-cell ,hypoleptinemia - Abstract
Leptin is an adipocyte-derived hormone that controls food intake and reproductive and immune functions in rodents. In uncontrolled human studies, low leptin levels are associated with impaired immune responses and reduced T-cell counts; however, the effects of leptin replacement on the adaptive immune system have not yet been reported in the context of randomized, controlled studies and/or in conditions of chronic acquired leptin deficiency. To address these questions, we performed a randomized, double-blinded, placebo-controlled trial of recombinant methionyl-human leptin (metreleptin) administration in replacement doses in women experiencing the female triad (hypothalamic amenorrhea) with acquired chronic hypoleptinemia induced by negative energy balance. Metreleptin restored both CD4(+) T-cell counts and their in vitro proliferative responses in these women. These changes were accompanied by a transcriptional signature in which genes relevant to cell survival and hormonal response were up-regulated, and apoptosis genes were down-regulated in circulating immune cells. We also observed that signaling pathways involved in cell growth/survival/proliferation, such as the STAT3, AMPK, mTOR, ERK1/2, and Akt pathways, were activated directly by acute in vivo metreleptin administration in peripheral blood mononuclear cells and CD4(+) T-cells both from subjects with chronic hypoleptinemia and from normoleptinemic, lean female subjects. Our data show that metreleptin administration, in doses that normalize circulating leptin levels, induces transcriptional changes, activates intracellular signaling pathways, and restores CD4(+) T-cell counts. Thus, metreleptin may prove to be a safe and effective therapy for selective CD4(+) T-cell immune reconstitution in hypoleptinemic states such as tuberculosis and HIV infection in which CD4(+) T cells are reduced.
- Published
- 2013
4. Leptin is an effective treatment for hypothalamic amenorrhea
- Author
-
Huizhi Gong, Giuseppe Matarese, Christos S. Mantzoros, Mary Brinkoetter, Chuanyun Gao, Kalliopi M. Arampatzi, Xiaowen Liu, John P. Chamberland, Sharon H. Chou, Rianna Stefanakis, Chou, Sh, Chamberland, Jp, Liu, X, Matarese, Giuseppe, Gao, C, Stefanakis, R, Brinkoetter, Mt, Gong, H, Arampatzi, K, and Mantzoros, Cs
- Subjects
Adult ,Leptin ,medicine.medical_specialty ,Hypothalamo-Hypophyseal System ,Time Factors ,Adolescent ,Pituitary-Adrenal System ,030209 endocrinology & metabolism ,Hypothalamic disease ,Bone remodeling ,Feeding and Eating Disorders ,03 medical and health sciences ,Metreleptin ,chemistry.chemical_compound ,Eating ,0302 clinical medicine ,Internal medicine ,medicine ,Endocrine system ,Humans ,Amenorrhea ,030304 developmental biology ,2. Zero hunger ,Bone mineral ,0303 health sciences ,Multidisciplinary ,business.industry ,Thyroid ,Biological Sciences ,medicine.disease ,3. Good health ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Female ,medicine.symptom ,business ,Hypothalamic Diseases - Abstract
Hypothalamic amenorrhea (HA) is associated with dysfunction of the hypothalamic-pituitary-peripheral endocrine axes, leading to infertility and bone loss, and usually is caused by chronic energy deficiency secondary to strenuous exercise and/or decreased food intake. Energy deficiency also leads to hypoleptinemia, which has been proposed, on the basis of observational studies as well as an open-label study, to mediate the neuroendocrine abnormalities associated with this condition. To prove definitively a causal role of leptin in the pathogenesis of HA, we performed a randomized, double-blinded, placebo-controlled trial of human recombinant leptin (metreleptin) in replacement doses over 36 wk in women with HA. We assessed its effects on reproductive outcomes, neuroendocrine function, and bone metabolism. Leptin replacement resulted in recovery of menstruation and corrected the abnormalities in the gonadal, thyroid, growth hormone, and adrenal axes. We also demonstrated changes in markers of bone metabolism suggestive of bone formation, but no changes in bone mineral density were detected over the short duration of this study. If these data are confirmed, metreleptin administration in replacement doses to normalize circulating leptin levels may prove to be a safe and effective therapy for women with HA.
- Published
- 2011
5. Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach.
- Author
-
Theodorakis MJ, Katsiki N, Arampatzi K, and Chrousos GP
- Subjects
- Adult, Aged, Aged, 80 and over, Bayes Theorem, Blood Glucose analysis, Diabetes Mellitus, Type 2 blood, Female, Humans, Insulin metabolism, Insulin Resistance, Insulin Secretion, Male, Middle Aged, Glucose Intolerance diagnosis, Glucose Tolerance Test
- Abstract
Objective: The conventional approach to analyzing data from oral glucose tolerance testing (OGTT) requires model identification in each individual separately (standard two stage, STS), ignoring knowledge about the population as a whole. In practice, however, the OGTT is sparsely sampled and individual estimates are often not resolvable from available data. This weakness is often encountered in large scale trials or epidemiological studies, leading to either multiple imputations or simply much less data available for analysis., Methods: We have applied a population approach, nonlinear mixed effects modeling, to plasma glucose, insulin and C-peptide data obtained from a 120 minute OGTT undertaken by 106 subjects with varying glucose tolerance. This method provides estimates of population means, variances and covariances of model parameters and empirical Bayes estimates of individual parameter values, as well as measures of intra-individual (within-subject) and inter-individual (between-subject) variability. The recently developed oral glucose minimal model was used to evaluate insulin sensitivity, and a combined model approach was used to assess β-cell secretion., Results: Applying these models allowed for the reconstruction of insulin secretion and glucose absorption profiles and gave population indexes of insulin sensitivity (S
I = 6.51 ± 1.20 × 10-4 min-1 ·μU-1 ·ml), fractional hepatic extraction of insulin (F = 0.522 ± 0.291) and fractional insulin clearance (kI = 0.258 ± 0.151 min-1 ). Whereas the traditional approach to parameter estimation failed to recover estimates in more than one third of the population, the population approach provided individual estimates in all subjects. Examination of the empirical Bayes estimates showed that individual parameter estimates were able to differentiate well between individuals at glucose tolerant states ranging from euglycemia to overt type 2 diabetes., Conclusions: Our findings suggest that population analysis is a powerful tool for obtaining accurate assessments of indexes of insulin sensitivity and β-cell function from the OGTT, especially in epidemiological studies with large numbers of sparsely sampled subjects.- Published
- 2017
- Full Text
- View/download PDF
6. Leptin is an effective treatment for hypothalamic amenorrhea.
- Author
-
Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R, Brinkoetter MT, Gong H, Arampatzi K, and Mantzoros CS
- Subjects
- Adolescent, Adult, Amenorrhea blood, Eating drug effects, Feeding and Eating Disorders blood, Feeding and Eating Disorders drug therapy, Female, Humans, Hypothalamic Diseases blood, Hypothalamo-Hypophyseal System metabolism, Leptin administration & dosage, Leptin blood, Pituitary-Adrenal System metabolism, Time Factors, Amenorrhea drug therapy, Hypothalamic Diseases drug therapy, Leptin analogs & derivatives
- Abstract
Hypothalamic amenorrhea (HA) is associated with dysfunction of the hypothalamic-pituitary-peripheral endocrine axes, leading to infertility and bone loss, and usually is caused by chronic energy deficiency secondary to strenuous exercise and/or decreased food intake. Energy deficiency also leads to hypoleptinemia, which has been proposed, on the basis of observational studies as well as an open-label study, to mediate the neuroendocrine abnormalities associated with this condition. To prove definitively a causal role of leptin in the pathogenesis of HA, we performed a randomized, double-blinded, placebo-controlled trial of human recombinant leptin (metreleptin) in replacement doses over 36 wk in women with HA. We assessed its effects on reproductive outcomes, neuroendocrine function, and bone metabolism. Leptin replacement resulted in recovery of menstruation and corrected the abnormalities in the gonadal, thyroid, growth hormone, and adrenal axes. We also demonstrated changes in markers of bone metabolism suggestive of bone formation, but no changes in bone mineral density were detected over the short duration of this study. If these data are confirmed, metreleptin administration in replacement doses to normalize circulating leptin levels may prove to be a safe and effective therapy for women with HA.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.